All News

vitamins.png

ACP Position Paper on Dietary Supplements

Jack Cush, MD

More than half of U.S. adults use dietary supplements, yet only a quarter use supplements recommended by a healthcare professional, and current law lets supplements reach the market with no premarket safety evaluation, unlike drugs or food additives.

Read Article
uric.acid.test

Saliva and Uric Acid Testing

Jack Cush, MD

A recent report from China reaffirms the potential utility of salivary uric acid (UA) testing  delivers smartphone-guided, enzyme-free gout screening at home for pennies per test.

Read Article
RheumNow Podcast square

Gout Cavalcade (7.10.2026)

Jack Cush, MD

Dr. Jack Cush reviews the news, journal articles and regulatory decisions from the past week. July is Gout: More than Flares month.

Read Article
Gout pills injection

Problems with treatment adherence in the management of gout

N. Lawrence Edwards, MD, MACP, MACR

Compared to common medical conditions such as hypertension, type 2 diabetes, hyperlipidemia or osteoporosis, where the reported drug adherence rates are between 50% to 70%, the drug adherence for gout is 37%.

Read Article
awards.many_.jpg

Brenda McShan: The Creative Heart of RheumNow

Jack Cush, MD

A pivotal member of the RheumNow family, Brenda McShan, will be retiring with honors.

Read Article
pregnancy,embryo,fetal

No Fetal Risks with First Trimester NSAID Use

Jack Cush, MD

PLoS Medicine has published a population-based retrospective cohort study from the Southern Israeli Pregnancy Registry (siPREG) project showing that 1st trimester exposure to NSAIDs was not associated with major congenital malformatoin (MCM) risk. 

Read Article
back, LBP, spine, AS

JAMA Review on Low Back Pain

Jack Cush, MD

A comprehensive JAMA review synthesizes current evidence on the epidemiology, pathophysiology, clinical evaluation, and treatment of nonspecific low back pain, drawing on 108 publications identified from a PubMed search (2005–2026) and the most recent guidelines from the WHO, ACP, and NICE. While the primary audience is generalists, the review carries important implications for rheumatologists who regularly encounter patients with back pain in the context of inflammatory arthritis, axial spondyloarthritis, and other systemic diseases.

Read Article
RheumNow Podcast square

Do You Zoster Vaccinate? (6.19.2026)

Jack Cush, MD

Dr. Jack Cush reviews the news, journal reports and best ways to review EULAR 2026.

Read Article
Challenges in Gout Diagnosis Dr. Angelo Gaffo in Birmingham, AL discusses the challenges in diagnosing gout. Presented as part of RheumNow's "Gout: More than Flares" campaign during the month of July 2026. https://t.co/LmTj7cvBGT https://t.co/VRVCrAo2TT

Links:

Dr. John Cush RheumNow ( View Tweet)
This is a great WISE read for yound doctors - from the great WISE Dr. Adam Cifu -- Advice for Internship https://t.co/BUtXzJxQxQ

Links:

Dr. John Cush RheumNow ( View Tweet)

"When you make the choice to avoid becoming the most experienced person in a room (whatever room you’re in), you’re making a bet about the future. " - Seth Godin https://t.co/oWtDNWeoND https://t.co/2dpiFRGaxZ

Links:

Dr. John Cush RheumNow ( View Tweet)
Digital Patient Education in RA Dr. Bella Mehta reviews abstract OP005-HPR presented in London at EULAR 2026 https://t.co/Wj8omKJTNx. https://t.co/h13p54BAHs

Links:

Dr. John Cush RheumNow ( View Tweet)
#EULAR2026 Signing off from the conference 🚆. A lot of learning points and things to consider for tomorrow’s practice, caught up with colleagues and formed new collaborations. Thank you @eular_org. Hope you enjoyed our @RheumNow coverage. See you in Berlin 🇩🇪 #EULAR2027 https://t.co/nyaBnHLrxr

Links:

Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
Top tips: ⭐️ Summarise the key facts but always provide the source ⭐️ Learn from mistakes to improve what you have ⭐️ Have high quality source material- scan multiple resources for the best quality info and latest news! @RheumNow #EULAR2026

Mrinalini Dey DrMiniDey ( View Tweet)

A Field Whose Time Has Come: Launching the EULAR Study Group on Geriatric Rheumatology EULAR launches a Study Group on Geriatric Rheumatology — clinics increasingly serve older patients with multimorbidity, polypharmacy, frailty, cognitive and functional limits, yet research

Dr. John Cush RheumNow ( View Tweet)

Rheumatology Shortage Cliff in Australia & USA Australia is facing a deepening rheumatology manpower crisis with direct parallels to the situation in the United States. The Australian Rheumatology Association's 2025 Workforce Report warns that the nation faces a significant https://t.co/qVziLM25JR
Dr. John Cush RheumNow ( View Tweet)
#EULAR2026 OP0125 It’s a case of “teamwork makes the dream work!” Instead of an index to capture heterogeneity in #Sjogren activity, the NECESSITY validated using data from 16 RCTs that a new composite tool, STAR has high sensitivity & specificity. Vital for use in RCTs @RheumNow https://t.co/ftx1uBP11A

Links:

Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
#EULAR2026 OP028 In 16 patients with AID (SSc,IIM, RA, IgG4,SjD, Grave’s), CD3xBCMA BiTE, Teclistamab was effective in 15/16. Duration of GC & DMARD-free was 11 mths. 2/16 need retreatment. All had low IgG and needed IVIG. Need long-term safety data & comparative study @RheumNow https://t.co/97MUPnXRua

Links:

Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
“Common sense in matters medical is rare, and is usually in inverse ratio to the degree of education.” – Sir William Osler

Dr. John Cush RheumNow ( View Tweet)

Join the global rheumatology community following RheumNow at #EULAR2026 ✔️ Trusted faculty voices ✔️ Fast, curated insights ✔️ Clinically relevant takeaways This is where rheumatology meets real-world practice. https://t.co/Hb88ZCP58P
Dr. John Cush RheumNow ( View Tweet)
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×